GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Medicines Co (NAS:MDCO) » Definitions » E10

The Medicines Co (The Medicines Co) E10 : $-1.80 (As of Sep. 2019)


View and export this data going back to 2000. Start your Free Trial

What is The Medicines Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

The Medicines Co's adjusted earnings per share data for the three months ended in Sep. 2019 was $-0.920. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.80 for the trailing ten years ended in Sep. 2019.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-05), The Medicines Co's current stock price is $84.90. The Medicines Co's E10 for the quarter that ended in Sep. 2019 was $-1.80. The Medicines Co's Shiller PE Ratio of today is .


The Medicines Co E10 Historical Data

The historical data trend for The Medicines Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Medicines Co E10 Chart

The Medicines Co Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 -0.06 -0.39 -1.35 -1.52

The Medicines Co Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.48 -1.52 -1.62 -1.71 -1.80

Competitive Comparison of The Medicines Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, The Medicines Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Medicines Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Medicines Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where The Medicines Co's Shiller PE Ratio falls into.



The Medicines Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, The Medicines Co's adjusted earnings per share data for the three months ended in Sep. 2019 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=-0.92/108.3294*108.3294
=-0.920

Current CPI (Sep. 2019) = 108.3294.

The Medicines Co Quarterly Data

per share eps CPI Adj_EPS
200912 -1.410 91.111 -1.676
201003 0.180 91.821 0.212
201006 0.290 91.962 0.342
201009 0.400 92.162 0.470
201012 1.100 92.474 1.289
201103 0.450 94.283 0.517
201106 0.210 95.235 0.239
201109 1.340 95.727 1.516
201112 0.350 95.213 0.398
201203 0.140 96.783 0.157
201206 0.250 96.819 0.280
201209 0.170 97.633 0.189
201212 0.380 96.871 0.425
201303 -0.210 98.209 -0.232
201306 0.300 98.518 0.330
201309 0.120 98.790 0.132
201312 0.020 98.326 0.022
201403 -0.080 99.695 -0.087
201406 -0.080 100.560 -0.086
201409 -0.260 100.428 -0.280
201412 -0.080 99.070 -0.087
201503 0.080 99.621 0.087
201506 -0.710 100.684 -0.764
201509 -1.570 100.392 -1.694
201512 -2.990 99.792 -3.246
201603 -1.340 100.470 -1.445
201606 2.520 101.688 2.685
201609 -1.230 101.861 -1.308
201612 -1.750 101.863 -1.861
201703 -1.440 102.862 -1.517
201706 -5.530 103.349 -5.796
201709 -0.420 104.136 -0.437
201712 -2.450 104.011 -2.552
201803 0.390 105.290 0.401
201806 -0.740 106.317 -0.754
201809 -0.750 106.507 -0.763
201812 -0.580 105.998 -0.593
201903 -0.800 107.251 -0.808
201906 -0.800 108.070 -0.802
201909 -0.920 108.329 -0.920

Add all the adjusted EPS together and divide 10 will get our e10.


The Medicines Co  (NAS:MDCO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


The Medicines Co E10 Related Terms

Thank you for viewing the detailed overview of The Medicines Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


The Medicines Co (The Medicines Co) Business Description

Traded in Other Exchanges
N/A
Address
8 Sylvan Way, Parsippany, NJ, USA, 07054
The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.
Executives
Alexander J Denner director C/O SARISSA CAPITAL MANAGEMENT LP, 660 STEAMBOAT ROAD, 3RD FLOOR, GREENWICH CT 06830
Peter Wijngaard officer: Chief Development Officer 8 SYLVAN WAY, PARSIPPANY NJ 07054
Paris Panayiotopoulos director ARIAD PHARMACEUTICALS, INC., 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139
Geno J Germano director 5 GIRALDA FARMS, MADISON NJ 07940
Sarah J. Schlesinger director C/O ARIAD PHARMACEUTICALS, 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139
Christopher T Cox officer: EVP & Chief Corp. Dev. Officer CADWALADER, WICKERSHAM & TAFT LLP, ONE WORLD FINANCIAL CENTER, NEW YORK NY 10281
Fredric N Eshelman director, officer: Executive Chairman PPD INC, 929 NORTH FRONT STREET, WILMINGTON NC 28401
Armin M Kessler director
Robert J Hugin director C/O THE MEDICINES CO, 8 CAMPUS DR, PARSIPPANY NJ 07054
Hiroaki Shigeta director THE MEDICINES COMPANY, 8 SYLVAN WAY, PARSIPPANY NJ 07054
Stuart A Kingsley officer: President and COO 152 CHESTNUT STREET, WEST NEWTON MA 02465
Robert G. Savage director C/O EPICEPT CORPORATION, 777 OLD SAW MILL ROAD, TARRYTOWN NY 10591
Glenn Sblendorio director, officer: President & CFO 3 TIMES SQAURE, 12TH FLOOR, NEW YORK NY 10036
James E Flynn 10 percent owner, other: Possible Members of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Members of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010

The Medicines Co (The Medicines Co) Headlines

From GuruFocus

Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 100,000 Shares

By GuruFocus Research GuruFocus Editor 03-02-2011

Medicines Company Reports Operating Results (10-Q)

By gurufocus 10qk 05-10-2010